Jefferies Maintains a 'Buy' on HEALTHSOUTH (HLS); No Rehab Needed..Expect Continued Outperformance
Tweet
Share
E-mailGet Alerts HLS Hot Sheet
Price: $49.41 --0%
Rating Summary:
8 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
8 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Jefferies maintains a 'Buy' on HEALTHSOUTH (NYSE: HLS) price target raised from $23 to $25.
Analyst, Arthur I. Henderson, said, "We believe HLS will continue to outperform Street expectations through disciplined operational and financial management. In addition, we believe concerns about potential Medicare IRF reimbursements cuts are overblown...FY12 EPS is expected to be $1.32-$1.39, which includes a 40% tax rate (up from 19% in 2011). Historically, management issues conservative guidance early in the year and raises it mid-year. We see no reason why this couldn't happen this year."
Henderson lowers FY12 EPS estimate from $1.40 to $1.36, establishes FY13 at $1.54.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $20.07 yesterday.
Analyst, Arthur I. Henderson, said, "We believe HLS will continue to outperform Street expectations through disciplined operational and financial management. In addition, we believe concerns about potential Medicare IRF reimbursements cuts are overblown...FY12 EPS is expected to be $1.32-$1.39, which includes a 40% tax rate (up from 19% in 2011). Historically, management issues conservative guidance early in the year and raises it mid-year. We see no reason why this couldn't happen this year."
Henderson lowers FY12 EPS estimate from $1.40 to $1.36, establishes FY13 at $1.54.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $20.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- UBS Downgrades Klarna (KLAR) to Neutral
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
